Hendrix S

References (2)

Title : Memantine ER Maintains Patient Response in Moderate to Severe Alzheimer's Disease: Post Hoc Analyses From a Randomized, Controlled, Clinical Trial of Patients Treated With Cholinesterase Inhibitors - Grossberg_2018_Alzheimer.Dis.Assoc.Disord_32_173
Author(s) : Grossberg GT , Alva G , Hendrix S , Ellison N , Kane MC , Edwards J
Ref : Alzheimer Disease & Associated Disorders , 32 :173 , 2018
Abstract : Grossberg_2018_Alzheimer.Dis.Assoc.Disord_32_173
ESTHER : Grossberg_2018_Alzheimer.Dis.Assoc.Disord_32_173
PubMedSearch : Grossberg_2018_Alzheimer.Dis.Assoc.Disord_32_173
PubMedID: 29771687

Title : Post Hoc Evidence for an Additive Effect of Memantine and Donepezil: Consistent Findings from DOMINO-AD Study and Memantine Clinical Trial Program - Hendrix_2015_J.Prev.Alzheimers.Dis_2_165
Author(s) : Hendrix S , Ellison N , Stanworth S , Otcheretko V , Tariot PN
Ref : J Prev Alzheimers Dis , 2 :165 , 2015
Abstract : Hendrix_2015_J.Prev.Alzheimers.Dis_2_165
ESTHER : Hendrix_2015_J.Prev.Alzheimers.Dis_2_165
PubMedSearch : Hendrix_2015_J.Prev.Alzheimers.Dis_2_165
PubMedID: 29226942